Case Study | March 19, 2013 | Hologic Inc.

Tséhootsooí Medical Center, Fort Defiance, Arizona

3D mammography (breast tomosynthesis) system

Christian Gomez, M.D., of the Tsehootsooi Medical Center, Fort Defiance, Arizona, credits the use of Hologic's 3D mammography system with helping its patient population avoid burdensome follow-up visits by providing more accurate, on-the-spot assessments of screening exams.


For years, high cancer diagnosis rates and limited access to quality health services plagued the Navajo residents cared for by the Tséhootsooí Medical Center in Fort Defiance, Arizona. 

Cultural, socioeconomic and distance barriers make it very difficult for women in the hospital’s service area to receive screening mammograms on a regular basis. The hospital experiences about a 50 percent no-show rate among its patients and only a staggering 20 percent of patients are able to return for follow-up visits.

“The majority of our patients live up to 200 miles away, roundtrip. Even if they can make the journey for their mammography screening exams, follow-up visits are usually out of the question. The challenge we’re facing is a ‘one and done barrier’ to patient care,” said Christopher Anthony, director of ancillary services at Tséhootsooí Medical Center. “If we don’t find the problem while the patient is here, we’re unlikely to get a second chance for further testing.” 

Faced with these daunting challenges, physicians at Fort Defiance felt tremendous pressure to provide their patients with the most complete and accurate mammography exams available and to drastically reduce the need to recall these patients. The hospital determined that the use of breast tomosynthesis, or 3D mammography, would make dramatic inroads in meeting the special needs of its patients. 

Tséhootsooí Medical Center installed a Hologic Selenia Dimensions tomosynthesis system in January of 2012 and its impact was felt immediately. During the first round of screening exams with the new system, a woman with extremely dense breasts was diagnosed with a stage 4 cancer that was not seen on the 2D digital mammogram.

Tomosynthesis provides a 3D image of the breast and gives radiologists a clearer view of areas within the breast that might otherwise be obstructed by overlapping tissue, if viewed on a conventional 2D mammogram. Although it provides benefit for all women, it is especially effective in women with dense breast tissue.  

A Quick and Conclusive Diagnosis Without Additional Imaging

“A lot of the credit for that positive reading has to go to the 3D mammography technology. The Dimensions system provided our physicians with a whole new vantage point for imaging the breast,” said Anthony. “Seeing the more complete view allowed our physicians to make a quick and conclusive diagnosis without requiring additional imaging. The ability to make a definitive diagnosis while the patient was here minimized the chance that she would be lost to follow-up, and let us get a head start on her treatment.”

Fort Defiance hopes that once word spreads about this new technology, patients will be less reluctant about coming in for their screenings, particularly if they are more confident they will receive conclusive results on their first visit, avoiding the burden of another long trip.

“Tomosynthesis helps our physicians provide more accurate, on-the-spot assessments, reduces our false positive recalls and minimizes the need for additional testing,” concludes Anthony. “We’re now able to provide a traditionally disenfranchised community the best possible care with limited time commitment on their end. We believe this will help save lives and provide women better peace of mind.”

Case study supplied by Hologic Inc.

The views and opinions expressed herein are those of Christopher Anthony and his colleagues at the Fort Defiance Indian Hospital and are not necessarily those of Hologic.

This information is intended for medical professionals in the U.S. and other markets and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and trade shows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, please contact your local Hologic representative or write to [email protected].

Hologic, Dimensions and Selenia are trademarks and/or registered trademarks of Hologic and/or its subsidiaries in the U.S. and/or other countries.


Related Content

News | Breast Imaging

April 2, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced ...

Time April 02, 2024
arrow
News | Breast Imaging

March 20, 2024 — Interval breast cancer is one that appears between two reviews of a screening program. That is, it is ...

Time March 20, 2024
arrow
News | Breast Imaging

March 15, 2024 — Screening-detected radial scars without atypia at core-needle biopsy (CNB) have a low upstaging rate to ...

Time March 15, 2024
arrow
News | Breast Imaging

March 6, 2024 — There is a pressing need to explore and understand which social determinants of health (SDOH) and health ...

Time March 06, 2024
arrow
News | Breast Imaging

February 20, 2024 — Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the ...

Time February 20, 2024
arrow
News | Breast Imaging

February 9, 2024 — An innovative breast imaging technique provides high sensitivity for detecting cancer while ...

Time February 09, 2024
arrow
News | Breast Density

December 22, 2023 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention ...

Time December 22, 2023
arrow
News | Breast Imaging

December 11, 2023 — A new deep learning challenge has been launched by the UEF Cancer AI research team, led by senior ...

Time December 11, 2023
arrow
News | RSNA

December 1, 2023 — The Society of Breast Imaging (SBI) announced that Elizabeth Morris, MD, has been selected as the SBI ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Breast cancer mortality is significantly reduced when women regularly attend screening mammograms ...

Time November 30, 2023
arrow
Subscribe Now